Reuters: Hot Stocks: Piper Jaffray says Theravance may be sold, shares jump

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Piper Jaffray says Theravance may be sold, shares jump Mar 4th 2013, 17:39 March 4 | Mon Mar 4, 2013 12:39pm EST March 4 (Reuters) - Shares of Theravance Inc rose 14 percent after a brokerage said a positive outcome for the company's respiratory drug could lead to a takeover of the company, which is one-quarter owned by GlaxoSmithKline Plc . "We believe approval for Anoro by year end could lead to an eventual takeout," Piper Jaffray analysts M Ian Somaiya, Do Kim and Matthew Luchini said in a note to clients. Glaxo and Theravance have a partnership to develop respiratory drugs, including Breo and Anoro to help succeed Glaxo's blockbuster Advair. Theravance could not immediately be reached for comment. Shares of Theravance, which has a market value of $2 billion, jumped to a high of $23.95 before easing back a little to $23.43 on the Nasdaq by early afternoon. (Reporting by Saumyadeb Chakrabarty in Bangalore; Editing by Roshni Menon)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions